RxDoctor Payments Data

Joseph Fiorillo

Medical Oncology · Eugene, ORNPI 1427250505

Payments from drug & device makers

What this record shows

This record is dominated by education: $47 of the $47 with a category attached, or 100.0%. E.r. Squibb & Sons, L.L.C. accounts for 74.4% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for medical oncology clinicians in OR, where the typical reported total is $810.

$47in general payments, 2019–2025

Across 3 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$35
  • Gilead$12
$857,289in research payments, 2019–2025

Across 484 payments — averaging $1771.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$225K
  • E.r. Squibb & Sons, L.L.C.$190K
  • Seagen Inc.$188K
  • Bayer$102K
  • Roche Products Limited$54K
  • GSK$35K
  • plus $62K from 5 others

What the payments were for

  • Education$47100%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.2$35
Gilead1$12

How this compares

$47 in reported general payments places this provider in the 15th percentile of 92 medical oncology providers in Oregon.

See all medical oncology providers in Oregon →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$11,491
Exemestane17$2,449
Anastrozole46$941
Ibandronate Sodium18$937
Acyclovir11$179

Paid to pharmacies, not to this prescriber.

Other medical oncology in Eugene

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →